Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Day One Biopharmaceuticals Inc’s current trading price is -31.38% away from its 52-week high, while its distance from the 52-week low is 11.41%. The stock’s price range during this period has varied between $11.13 and $18.07. The company, active in the Healthcare sector, saw a trading volume of around 1.56 million for the day, considerably higher average daily volume of 1.12 million observed over the last three months.
Day One Biopharmaceuticals Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $18.07 on 05/01/24, and the lowest price during the same period was recorded at $11.13 on 01/14/25.
How Financial Performance Impacts Market Capitalization
Day One Biopharmaceuticals Inc (DAWN) has experienced a quarterly decline of -16.39% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.25B and boasts a workforce of 155 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 13.77, with a change in price of -1.28. Similarly, Day One Biopharmaceuticals Inc recorded 1,059,787 in trading volume during the last 100 days, posting a change of -9.36%.
How DAWN’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for DAWN stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
DAWN Stock Stochastic Average
As of today, the raw stochastic average of Day One Biopharmaceuticals Inc over the past 50 days is 22.56%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 58.53%. Additionally, the Stochastic %K and %D values for the company were 31.34% and 16.34%, respectively, over the past 20 days.
DAWN Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -2.13%.However, over the last six months, we can see a stronger performance of -20.77%. Over the last 30 days, the price of DAWN has leaped by -2.75%. And in the last five days, it has surged by 1.64%.
